|
US4038412A
(en)
|
1975-08-25 |
1977-07-26 |
Richardson-Merrell Inc. |
N-(phenylether-substituted benzyl)alkanediamines
|
|
DE2616484C3
(de)
|
1976-04-14 |
1981-02-26 |
A. Nattermann & Cie Gmbh, 5000 Koeln |
Basische Benzoyläther, deren Salze und quartäre Ammoniumverbindungen sowie Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
|
|
CA1118422A
(en)
|
1978-11-20 |
1982-02-16 |
Herbert J. Havera |
Trans-2-substituted-amido-hexahydrobenzo [a] quinolizines
|
|
IL94466A
(en)
|
1989-05-25 |
1995-01-24 |
Erba Carlo Spa |
Pharmaceutical preparations containing the history of A-amino carboxamide N-phenylalkyl are converted into such new compounds and their preparation
|
|
IE903196A1
(en)
|
1989-09-05 |
1991-03-13 |
Searle & Co |
Substituted n-benzylpiperidine amides
|
|
US5212182A
(en)
|
1990-10-03 |
1993-05-18 |
American Home Products Corpooration |
Substituted quinolinyl- and naphthalenylbenzamides or benzylamines and related compounds useful as analgesics
|
|
GB9321812D0
(en)
|
1993-10-22 |
1993-12-15 |
Smithkline Beecham Plc |
Pharmaceuticals
|
|
US5432198A
(en)
|
1994-08-18 |
1995-07-11 |
Sphinx Pharmaceuticals Corporation |
Vicinal-substituted carbocyclic compounds as therapeutic agents
|
|
US6506876B1
(en)
|
1994-10-11 |
2003-01-14 |
G.D. Searle & Co. |
LTA4 hydrolase inhibitor pharmaceutical compositions and methods of use
|
|
US5585492A
(en)
|
1994-10-11 |
1996-12-17 |
G. D. Searle & Co. |
LTA4 Hydrolase inhibitors
|
|
GB9515412D0
(en)
|
1995-07-27 |
1995-09-27 |
Pharmacia Spa |
2-(4-substituted)-benzylamino-2-methyl-propanamide derivatives
|
|
AU4020897A
(en)
|
1996-08-17 |
1998-03-06 |
Zeneca Limited |
3-mercaptopyrrolidines as farnesyl protein transferase inhibitors
|
|
US6207665B1
(en)
|
1997-06-12 |
2001-03-27 |
Schering Aktiengesellschaft |
Piperazine derivatives and their use as anti-inflammatory agents
|
|
ATE268751T1
(de)
|
1997-11-20 |
2004-06-15 |
Teijin Ltd |
Biphenylamidin-derivate
|
|
CA2315109A1
(en)
|
1997-12-19 |
1999-07-01 |
Novo Nordisk A/S |
Modification of polysaccharides by means of a phenol oxidizing enzyme
|
|
US6399629B1
(en)
*
|
1998-06-01 |
2002-06-04 |
Microcide Pharmaceuticals, Inc. |
Efflux pump inhibitors
|
|
WO2000069811A1
(en)
|
1999-05-17 |
2000-11-23 |
Teijin Limited |
Cyanobiphenyl derivatives
|
|
MXPA02002559A
(es)
|
1999-09-10 |
2002-07-30 |
Merck & Co Inc |
Inhibidores de tirosina cinasa.
|
|
EP1227084B1
(en)
|
1999-10-28 |
2005-12-14 |
Trine Pharmaceuticals, Inc. |
Drug discharge pump inhibitors
|
|
DE60132975T2
(de)
|
2000-01-06 |
2009-02-26 |
Merck Frosst Canada Inc., Kirkland |
Neue substanzen und verbindungen als protease-inhibitoren
|
|
AU2868601A
(en)
|
2000-01-27 |
2001-08-07 |
Ribotargets Ltd |
Biaryl compounds, their preparation and their use in therapy
|
|
DE60139429D1
(de)
*
|
2000-02-16 |
2009-09-10 |
Smithkline Beecham Plc |
Pyrimidin-5-Onderivate als LDL-PLA2 Inhibitoren
|
|
US7001905B2
(en)
|
2000-03-15 |
2006-02-21 |
Warner-Lambert Company |
Substituted diarylamines as MEK inhibitors
|
|
JP2004507456A
(ja)
|
2000-05-11 |
2004-03-11 |
ブリストル−マイヤーズ スクイブ カンパニー |
成長ホルモン分泌促進薬として有用なテトラヒドロイソキノリン類縁体
|
|
US20020032238A1
(en)
|
2000-07-08 |
2002-03-14 |
Henning Priepke |
Biphenylcarboxylic acid amides, the preparation thereof and the use thereof as medicaments
|
|
AU2001286909B2
(en)
|
2000-09-01 |
2006-02-09 |
Bayer Cropscience Ag |
Disubstituted benzenes as insecticides
|
|
HUP0303360A2
(hu)
|
2000-09-25 |
2004-01-28 |
Actelion Pharmaceuticals Ltd. |
Maláriaellenes hatású szubsztituált amino-aza-cikloalkánok és ezeket tartalmazó gyógyszerkészítmények
|
|
GB0024807D0
(en)
|
2000-10-10 |
2000-11-22 |
Smithkline Beecham Plc |
Novel compounds
|
|
GB0024808D0
(en)
|
2000-10-10 |
2000-11-22 |
Smithkline Beecham Plc |
Novel compounds
|
|
EP1217000A1
(en)
|
2000-12-23 |
2002-06-26 |
Aventis Pharma Deutschland GmbH |
Inhibitors of factor Xa and factor VIIa
|
|
WO2002060861A1
(en)
|
2001-01-29 |
2002-08-08 |
Teijin Limited |
Benzamidine derivatives and process for production thereof
|
|
AR035425A1
(es)
|
2001-01-30 |
2004-05-26 |
Teijin Ltd |
Cristal de diclorhidrato del acido 3-(3-amidinofenil)-5-[({[1-(iminoetil)-4-piperidil]metil}amino)metil]benzoico y proceso para prepararlo
|
|
DE60229114D1
(en)
|
2001-03-02 |
2008-11-13 |
Axys Pharm Inc |
Cathepsincystein-proteasehemmer
|
|
WO2002083641A2
(en)
|
2001-04-17 |
2002-10-24 |
Actelion Pharmaceuticals Ltd. |
Amino-aza-cyclohexanes for the treatment of malaria
|
|
JP4619655B2
(ja)
*
|
2001-09-14 |
2011-01-26 |
ハイ・ポイント・ファーマスーティカルズ、エルエルシー |
新規アミノアゼチジン、−ピロリジンおよび−ピペリジン誘導体
|
|
US20030186963A1
(en)
*
|
2001-09-14 |
2003-10-02 |
Dorwald Florencio Zaragoza |
Substituted piperidines
|
|
KR20040047869A
(ko)
|
2001-09-26 |
2004-06-05 |
파마시아 이탈리아 에스.피.에이. |
키나제 억제제로서 활성인 아미노인다졸 유도체, 이의제조방법 및 이를 함유하는 약제학적 조성물
|
|
AU2002363236A1
(en)
|
2001-10-30 |
2003-05-12 |
Millennium Pharmaceuticals, Inc. |
Compounds, pharmaceutical compositions and methods of use therefor
|
|
US6649606B1
(en)
|
2001-11-09 |
2003-11-18 |
Bristol-Myers Squibb Co. |
Tetrahydroisoquinoline analogs as modulators of chemokine receptor activity
|
|
KR100718397B1
(ko)
|
2002-02-13 |
2007-05-14 |
피피지 인더스트리즈 오하이오 인코포레이티드 |
기판상에 다층 복합 코팅을 형성하기 위한 코팅 라인 및방법
|
|
US6660736B2
(en)
|
2002-03-27 |
2003-12-09 |
Hoffmann-La Roche Inc. |
Phthalimido derivatives and a process for their preparation
|
|
CN1656079A
(zh)
|
2002-05-31 |
2005-08-17 |
卫材株式会社 |
吡唑化合物和含有该化合物的药物组合物
|
|
JP2005194193A
(ja)
|
2002-06-11 |
2005-07-21 |
Taisho Pharmaceut Co Ltd |
ケモカイン受容体拮抗化合物
|
|
WO2004005267A2
(en)
|
2002-07-03 |
2004-01-15 |
Janssen Pharmaceutica, N.V. |
Heteroaryl compounds useful in treating inflammatory disorders
|
|
JP2005538975A
(ja)
|
2002-07-03 |
2005-12-22 |
アステックス テクノロジー リミテッド |
p38MAPキナーゼ阻害薬としての3−(ヘテロ)アリールメトキシピリジン類およびそれらの類縁体
|
|
ATE404537T1
(de)
|
2002-08-13 |
2008-08-15 |
Shionogi & Co |
Heterocyclische verbindungen mit hiv-integrase- hemmender wirkung
|
|
ES2387803T3
(es)
|
2003-01-08 |
2012-10-02 |
Novartis Vaccines And Diagnostics, Inc. |
Agentes antibacterianos
|
|
PT2476667E
(pt)
|
2003-02-26 |
2014-09-18 |
Sugen Inc |
Compostos de aminoheteroarilo como inibidores da proteína quinase
|
|
US20060178403A1
(en)
|
2003-03-07 |
2006-08-10 |
Neurocrine Biosciences, Inc. |
Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto
|
|
WO2004092123A2
(en)
|
2003-04-10 |
2004-10-28 |
Microbia, Inc. |
Inhibitors of fungal invasion
|
|
US7232825B2
(en)
|
2003-05-02 |
2007-06-19 |
Guoqing P Chen |
Phenylaminopyrimidine derivatives and methods of use
|
|
EP1644353A1
(de)
*
|
2003-07-02 |
2006-04-12 |
Bayer HealthCare AG |
Amid-substituierte 1, 2, 4-triazin-5 (2h) - one zur behandlung von chronisch inflammatorischen krankheiten
|
|
WO2005002673A1
(en)
|
2003-07-03 |
2005-01-13 |
Astex Therapeutics Limited |
Raf kinase inhibitors
|
|
US20070197541A1
(en)
|
2003-07-29 |
2007-08-23 |
Oyelere Adegboyega K |
Biaryl heterocyclic amines,amides, and sulfur-containing compounds and methods of making and using the same
|
|
US7094791B2
(en)
|
2003-07-31 |
2006-08-22 |
Avalon Pharmaceuticals, Inc. |
Derivatives of 3-hydroxy-pyrrole-2,4-dicarboxylic acid and uses thereof
|
|
US7572816B2
(en)
|
2003-08-01 |
2009-08-11 |
Auspex Pharmaceuticals, Inc. |
Therapeutic agents for the treatment of cancer, metabolic diseases and skin disorders
|
|
CN1902171A
(zh)
|
2003-11-10 |
2007-01-24 |
舍林股份公司 |
用作ccr-5拮抗剂的苄醚胺化合物
|
|
EP1535908A1
(en)
|
2003-11-24 |
2005-06-01 |
Newron Pharmaceuticals S.p.A. |
N-acyl-N'-benzyl-alkylendiamino drivatives
|
|
JP2007517843A
(ja)
|
2004-01-05 |
2007-07-05 |
アストラゼネカ アクチボラグ |
Chk1阻害剤であるチオフェン誘導体
|
|
WO2005087236A1
(en)
|
2004-03-11 |
2005-09-22 |
Glaxo Group Limited |
Novel m3 muscarinic acetylcholine receptor antagonists
|
|
SE0401342D0
(sv)
|
2004-05-25 |
2004-05-25 |
Astrazeneca Ab |
Therapeutic compounds
|
|
US20070275968A1
(en)
|
2004-09-07 |
2007-11-29 |
Hitoshi Kurata |
Substituted Biphenyl Derivative
|
|
JP2008520579A
(ja)
|
2004-11-15 |
2008-06-19 |
グラクソ グループ リミテッド |
新規m3ムスカリン性アセチルコリン受容体アンタゴニスト
|
|
ATE457302T1
(de)
|
2004-11-24 |
2010-02-15 |
Lilly Co Eli |
Aromatische etherderivate als thrombin-hemmer
|
|
DE102004061008A1
(de)
|
2004-12-18 |
2006-06-22 |
Bayer Healthcare Ag |
3-Arylalkyl- und 3-Heteroarylalkyl-substituierte 1,2,4-Triazin-5(2H)-one
|
|
DE102004061006A1
(de)
|
2004-12-18 |
2006-06-22 |
Bayer Healthcare Ag |
3-Benzylthio-1,2,4-triazin-5(2H)-one
|
|
GT200600042A
(es)
|
2005-02-10 |
2006-09-27 |
Aventis Pharma Inc |
Compuestos de bis arilo y heteroarilo sustituido como antagonistas selectivos de 5ht2a
|
|
AU2006214184B2
(en)
|
2005-02-17 |
2012-02-02 |
Albany Molecular Research, Inc. |
Benzoxazole carboxamides for treating CINV and IBS-D
|
|
WO2006138475A2
(en)
|
2005-06-16 |
2006-12-28 |
Jenrin Discovery |
Mao-b inhibitors useful for treating obesity
|
|
US20070015832A1
(en)
|
2005-07-14 |
2007-01-18 |
Myriad Genetics, Incorporated |
Methods of treating overactive bladder and urinary incontinence
|
|
EP2359943B1
(en)
|
2005-11-08 |
2014-01-22 |
SurModics, Inc. |
Ultra-thin photo-polymeric coatings and uses thereof
|
|
EP3205644A1
(en)
*
|
2005-12-29 |
2017-08-16 |
Celtaxsys Inc. |
Diamine derivatives as inhibitors of leukotriene a4 hydrolase
|
|
ITMI20060179A1
(it)
|
2006-02-02 |
2007-08-03 |
Abiogen Pharma Spa |
Procedimento per la risoluzione di miscele racemiche e complesso diastereoisomerico di un agente risolvente e di unantiomero di interesse
|
|
EP2027119A2
(en)
|
2006-05-18 |
2009-02-25 |
Arena Pharmaceuticals, Inc. |
Ethers, secondary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
|
|
TW200808705A
(en)
|
2006-06-15 |
2008-02-16 |
Sanofi Aventis |
Aryl- and heteroaryl-ethyl-acylguanidine derivatives, their preparation and their application in therapeutics
|
|
JPWO2008023720A1
(ja)
|
2006-08-23 |
2010-01-14 |
アステラス製薬株式会社 |
ウレア化合物又はその塩
|
|
EP2102158A1
(en)
|
2006-12-11 |
2009-09-23 |
Topo Target A/S |
Prodrugs of diphenyl ox- indol- 2 -one compounds for the treatment of cancers
|
|
CL2007003874A1
(es)
|
2007-01-03 |
2008-05-16 |
Boehringer Ingelheim Int |
Compuestos derivados de benzamida; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar enfermedades cardiovasculares, hipertension, aterosclerosis, reestenosis, ictus, insuficiencia cardiaca, lesion isquemica, hipertensio
|
|
SA08280783B1
(ar)
|
2007-01-11 |
2011-04-24 |
استرازينيكا ايه بي |
مشتقات بيريدوبيريميدين كمثبطات pde4
|
|
CN101583598B
(zh)
|
2007-01-15 |
2012-09-12 |
参天制药株式会社 |
具有IκB激酶β抑制活性的新型吲哚衍生物
|
|
US20080200454A1
(en)
|
2007-02-15 |
2008-08-21 |
Ameriks Michael K |
Carbon-linked tetrahydro-pyrazolo-pyridine modulators of cathepsin s
|
|
WO2008101195A2
(en)
|
2007-02-16 |
2008-08-21 |
Othera Holding, Inc. |
Drug resistance reversal in neoplastic disease
|
|
CN103497148B
(zh)
|
2007-02-22 |
2016-06-01 |
科尔比制药公司 |
羟胺化合物及其用法
|
|
JP2010120852A
(ja)
|
2007-03-09 |
2010-06-03 |
Daiichi Sankyo Co Ltd |
新規なジアミド誘導体
|
|
US20100256147A1
(en)
*
|
2007-04-13 |
2010-10-07 |
Hangauer Jr David G |
Biaryl acetamide derivatives as modulators of the kinase cascade for the treatment of hearing loss, osteoporosis and cell proliferation disorders
|
|
WO2009002495A1
(en)
|
2007-06-27 |
2008-12-31 |
Merck & Co., Inc. |
4-carboxybenzylamino derivatives as histone deacetylase inhibitors
|
|
CL2008001943A1
(es)
|
2007-07-02 |
2009-09-11 |
Boehringer Ingelheim Int |
Compuestos derivados de fenil-triazol, inhibidores de enzimas de señales especificas que participan del control de la proliferacion celular; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar cancer, infecciones, enfermedades inflamatorias y autoinmunes.
|
|
WO2009048547A1
(en)
|
2007-10-10 |
2009-04-16 |
Merck & Co., Inc. |
Diphenyl substituted cycloalkanes
|
|
EP2217580B1
(en)
|
2007-10-12 |
2011-12-21 |
ArQule, Inc. |
Substituted tetrazole compounds and uses thereof
|
|
CN101903021B
(zh)
|
2007-12-19 |
2012-11-14 |
纽朗制药有限公司 |
用于治疗精神病的α-氨基酰胺衍生物
|
|
WO2009091388A2
(en)
*
|
2007-12-21 |
2009-07-23 |
Progenics Pharmaceuticals, Inc. |
Triazines and related compounds having antiviral activity, compositions and methods thereof
|
|
CL2009000249A1
(es)
|
2008-02-06 |
2009-09-11 |
Glaxo Group Ltd |
Compuestos derivados de pirazolo[3,4-b] piridin-butanodiamida; composicion farmaceutica; y su uso en el tratamiento del asma, enfermedad pulmonar obstructiva cronica, rinitis, dermatitis atopica, psoriasis.
|
|
AR070564A1
(es)
|
2008-02-06 |
2010-04-21 |
Glaxo Group Ltd |
Derivados de 1h-pirazolo[3,4-b]piridin-5-ilo,inhibidores de fosfodiesterasas pde4 y antagonistas de receptores muscarinicos de acetilcolina(machr), utiles en el tratamiento y/o profilaxis de enfermedades respiratorias y alergicas,y composiciones farmaceuticas que los comprenden
|
|
CN102015705B
(zh)
|
2008-02-26 |
2013-11-13 |
武田药品工业株式会社 |
稠合的杂环衍生物及其用途
|
|
US20110130386A1
(en)
|
2008-04-25 |
2011-06-02 |
Mark Frigerio |
Dna-pk inhibitors
|
|
EP2277861A4
(en)
|
2008-05-07 |
2012-05-02 |
Dainippon Sumitomo Pharma Co |
CYCLIC AMIN-1-CARBOXYLIC ACID EST DERIVATIVE AND PHARMACEUTICAL COMPOSITION THEREWITH
|
|
WO2009158375A1
(en)
|
2008-06-25 |
2009-12-30 |
Abbott Laboratories |
Aza-cylic indole- 2 -carboxamides and methods of use thereof
|
|
EP2348855A4
(en)
|
2008-09-17 |
2013-01-09 |
Burnham Inst Medical Research |
Small-molecule bonds for stem cell differentiation
|
|
EA019520B1
(ru)
|
2008-10-31 |
2014-04-30 |
Сионоги Энд Ко., Лтд. |
Цефалоспорины, содержащие катехольную группу
|
|
WO2010052448A2
(en)
|
2008-11-05 |
2010-05-14 |
Ucb Pharma S.A. |
Fused pyrazine derivatives as kinase inhibitors
|
|
WO2010111353A1
(en)
|
2009-03-25 |
2010-09-30 |
Acadia Pharmaceuticals, Inc. |
N-substituted piperidine derivatives as serotonin receptor agents
|
|
US20120083476A1
(en)
|
2009-06-05 |
2012-04-05 |
Janssen Pharmaceutica Nv |
Heteroaryl-substituted spirocyclic diamine urea modulators of fatty acid amide hydrolase
|
|
BR112012004149A2
(pt)
|
2009-08-25 |
2016-03-22 |
Abraxis Bioscience Llc |
terapia de combinação com composições de nanopartículas de taxano e inibidores de hedgehog
|
|
EP2493852B1
(en)
*
|
2009-10-30 |
2014-04-09 |
Janssen Pharmaceutica NV |
4-substituted-2-phenoxy-phenylamine delta opioid receptor modulators
|
|
GB0919431D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Novel compounds
|
|
TWI503323B
(zh)
|
2010-03-29 |
2015-10-11 |
Oncotherapy Science Inc |
三環化合物以及含此化合物之pbk抑制劑
|
|
AU2011236933A1
(en)
|
2010-04-05 |
2013-05-02 |
Shionogi & Co., Ltd. |
Cephem compound having catechol group
|
|
EP2590656B1
(en)
|
2010-07-07 |
2017-11-15 |
Ardelyx, Inc. |
Compounds and methods for inhibiting phosphate transport
|
|
EP2591354B1
(en)
|
2010-07-07 |
2016-09-07 |
Ardelyx, Inc. |
Compounds and methods for inhibiting phosphate transport
|
|
WO2012022487A1
(de)
*
|
2010-08-20 |
2012-02-23 |
Grünenthal GmbH |
Substituierte cyclische carboxamid- und harnstoff-derivate als liganden des vanilloid-rezeptors
|
|
US8835472B2
(en)
|
2010-09-02 |
2014-09-16 |
Boehringer Ingelheim International Gmbh |
Compounds, pharmaceutical compositions and uses thereof
|
|
US8722076B2
(en)
|
2010-09-30 |
2014-05-13 |
Surmodics, Inc. |
Photochrome- or near IR dye-coupled polymeric matrices for medical articles
|
|
WO2012068589A2
(en)
|
2010-11-19 |
2012-05-24 |
Constellation Pharmaceuticals |
Modulators of methyl modifying enzymes, compositions and uses thereof
|
|
WO2012079154A1
(en)
|
2010-12-14 |
2012-06-21 |
Dalhousie University |
Selective estrogen receptor modulators
|
|
EP2716642B1
(en)
|
2011-05-30 |
2016-07-20 |
Astellas Pharma Inc. |
Imidazopyridine compound
|
|
JP2013047223A
(ja)
*
|
2011-07-28 |
2013-03-07 |
Otsuka Pharmaceut Co Ltd |
医薬
|
|
TW201329025A
(zh)
|
2011-11-01 |
2013-07-16 |
Astex Therapeutics Ltd |
醫藥化合物
|
|
GB201118876D0
(en)
*
|
2011-11-01 |
2011-12-14 |
Astex Therapeutics Ltd |
Pharmaceutical compounds
|
|
AU2012335978A1
(en)
|
2011-11-08 |
2014-05-22 |
Arena Pharmaceuticals, Inc. |
Modulators of the G protein-coupled Mas receptor and the treatment of disorders related thereto
|
|
US9359346B2
(en)
|
2011-11-29 |
2016-06-07 |
Vivozon, Inc. |
Benzamide derivative and use thereof
|
|
JP2013112657A
(ja)
|
2011-11-30 |
2013-06-10 |
Toray Ind Inc |
フェノキシメチルベンズアミド誘導体、その薬学的に許容される酸付加塩及びその医薬用途
|
|
CN103130791B
(zh)
|
2011-11-30 |
2016-05-04 |
正大天晴药业集团股份有限公司 |
一种新型苯甲酰胺类化合物
|
|
CN103172512B
(zh)
|
2011-12-23 |
2016-08-03 |
中国医学科学院医药生物技术研究所 |
一组木豆素结构类似化合物、制备方法和应用
|
|
WO2013124169A1
(en)
|
2012-02-21 |
2013-08-29 |
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. |
Use of 1h-indazole-3-carboxamide compounds as glycogen synthase kinase 3 beta inhibitors
|
|
WO2013151991A1
(en)
|
2012-04-02 |
2013-10-10 |
Surmodics, Inc. |
Hydrophilic polymeric coatings for medical articles with visualization moiety
|
|
UY35103A
(es)
|
2012-10-29 |
2014-05-30 |
Glaxo Group Ltd |
Compuestos de cefem 2-sustituidos
|
|
US9624214B2
(en)
|
2012-11-05 |
2017-04-18 |
Bayer Pharma Aktiengesellschaft |
Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use
|
|
JP2016512543A
(ja)
|
2013-03-12 |
2016-04-28 |
アッヴィ・インコーポレイテッド |
ジヒドロ−ピロロピリジノンブロモドメイン阻害剤
|
|
EP2999345B1
(en)
|
2013-05-22 |
2022-08-10 |
Curza Global LLC |
Compositions and methods comprising a polyamine
|
|
JP6434968B2
(ja)
|
2013-07-02 |
2018-12-05 |
ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company |
Rock阻害剤としての三環式ピリド−カルボキサミド誘導体
|
|
CA2920565A1
(en)
|
2013-08-08 |
2015-02-12 |
Bayer Pharma Aktiengesellschaft |
Substituted pyrazolo[1,5-a]pyridine-3-carboxamides and use thereof
|
|
MX2016002544A
(es)
|
2013-09-04 |
2016-06-17 |
Squibb Bristol Myers Co |
Compuestos utiles como inmunomoduladores.
|
|
EP2857388A1
(de)
*
|
2013-10-01 |
2015-04-08 |
Grünenthal GmbH |
Sulfon-haltige Azole
|
|
US9458150B2
(en)
|
2013-11-08 |
2016-10-04 |
Rutgers, The State University Of New Jersey |
Antimicrobial agents
|
|
CA2967825A1
(en)
|
2014-11-14 |
2016-05-19 |
Melinta Therapeutics, Inc. |
Method for treating, preventing, or reducing the risk of skin infection
|